Acciones de Moderna se disparan un 90% tras éxito en ensayo de vacuna contra el cáncer en Fase 3
Tap title to read story
0:00 / 1:25
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story
Tap title to read story